Skip to main content
IAS 2025, the 13th IAS Conference on HIV Science

Press programme

IAS 2025 will be a hybrid conference, taking place in Kigali, Rwanda, and virtually from 13 to 17 July. The press programme will include three press conferences: one spotlighting key science featured at the conference; one launching the annual UNAIDS Global AIDS Update; and an opening press conference on the future of the global HIV response. 

alternative text

All press conferences will be accessible virtually. 

Press releases will be issued at the start of each press conference. Please note that each press conference has a unique registration link that you can find below or in the online press programme.  

All media are required to register for the conference. For more information, please visit the media registration webpage on the IAS 2025 website.  

Tuesday, 8 July 

Official IAS 2025 scientific highlights

Read the press release here

16:00 – 17:00 CAT
Format: Virtual
Registration link: Register and join here 

Speakers:

  • Dr Beatriz Grinsztejn, IAS President and IAS 2025 International Co-Chair 

  • Dr Jack Stone, University of Bristol, United Kingdom 
    Modelling the impact of cuts in PEPFAR funding for HIV pre-exposure prophylaxis among key populations in sub-Saharan Africa

  • Anna Grimsrud, Senior Technical Advisor, International AIDS Society 
    The impact of the U.S. funding interruption on HIV services and the HIV epidemic in Mozambique

  • Khensani Chauke, Gauteng Provincial Department of Health, Pretoria, South Africa
    Termination of the USAID APACE award in Johannesburg, South Africa: Impact on the number of people living with HIV tested, diagnosed and initiated on anti-retroviral therapy (ART) (January-March 2023-2025) 

  • Meg Stevenson, Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, United States 
    Impact of U.S. funding suspensions on community HIV response in the Latin America and Caribbean region 

  • Zackie Achmat, Founder of the Treatment Action Campaign and member of the Global HIV Treatment Coalition. 

Thursday, 10 July 

Launch of 2025 UNAIDS Global AIDS Update: AIDS, crisis and the power to transform 

Organized by UNAIDS In partnership with the South African National AIDS Council (SANAC)

11:30 – 12:30 CAT
Format: Hybrid
In-person location: Bertha Gxowa Hospital, Angus St, Germiston, Johannesburg, South Africa
Registration: The event will be livestreamed on Zoom
Meeting ID: 940 3779 4528 
Passcode: 222800 
 

Speakers:

  • Winnie Byanyima, Executive Director of UNAIDS and Under-Secretary-General of the United Nations 

  • Dr Aaron Motsoaledi, Minister of Health of South Africa   

  • Prof Helen Rees, Executive Director, Wits RHI (Wits Reproductive Health and HIV Institute)  

  • The Reverend Mbulelo Dyasi, Executive Director of SANARELA (South African Network of Religious Leaders Living with or Personally Affected by HIV & AIDS) 

Monday, 14 July 

Breakthroughs amid crisis: The future of HIV innovation 

15:30–16:30 CAT
Format: Hybrid
In-person location: Room AD12
Registration link: Register and join here

Speakers:

  • Dr Beatriz Grinsztejn, IAS President and IAS 2025 International Co-Chair 

  • Dr Meg Doherty, Director, Global HIV, Hepatitis and STIs Programmes and incoming Director of Science, Research, Evidence and Quality for Health at the World Health Organization (WHO) 

  • Winnie Byanyima, Executive Director of UNAIDS and Under-Secretary-General of the United Nations 

  • Esteban Burrone, Policy, Strategy and Market Access Director at the Medicines Patent Pool (MPP)
    Announcement of a new development in one of MPP HIV licenses 

  • Dr Rebeca Plank, Merck & Co., Inc., United States 
    Safety and pharmacokinetics of MK-8527 oral once-monthly: a phase 2 study in adults at low risk of HIV-1 exposure 


Please note that speakers are subject to change. 

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.